Market Overview

Benzinga's Top Pre-Market Losers

Share:
Related RIGL
Earnings Scheduled For March 3, 2015
Biotech Stocks Moving Higher
Bristol-Myers Inks Another Immuno-Oncology Drug Deal (Zacks)
Related ENDP
Benzinga's Top Downgrades
Growth Uncertainty For Endo Continues Through 2017

Rigel Pharmaceuticals (NASDAQ: RIGL) shares fell 30.96% to $5.82 in the pre-market trading. Rigel Pharmaceuticals' trailing-twelve-month ROE is -45.82%.

Endo Health Solutions (NASDAQ: ENDP) shares dropped 6.38% to $25.84 in pre-market trading. Endo cut its earnings view for 2012 and 2013.

Ciena (NASDAQ: CIEN) dipped 1.73% to $15.30 in the pre-market session. Ciena posted a wider fiscal fourth-quarter loss.

Canadian Solar (NASDAQ: CSIQ) dipped 1.33% to $2.97 in the pre-market session. Canadian Solar named Guangchun Zhang as its Chief Operating Officer.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (CIEN + CSIQ)

View Comments and Join the Discussion!

Get Benzinga's Newsletters